Amid overwhelming public demand for alternative COVID-19 vaccines, IHH Singapore officially began offering its first batch of 10,000 doses of the Sinopharm COVID-19 vaccine on 30 August.
With this first batch of 10,000 doses offered across Gleneagles Hospital, Mount Elizabeth Hospital and Parkway Shenton clinics in Duxton and One Raffles Quay, IHH Singapore is able to inoculate some 5,000 people.
Dr Noel Yeo, Chief Operating Officer of IHH Healthcare Singapore, said that more than 6,000 individuals had registered their interest to receive the Sinopharm vaccine even before it was made available.
"We were aware there is a demand for alternative vaccines. However, the response for Sinopharm has been overwhelming. We are making plans for second orders but we have to clear approvals from HSA (Health Sciences Authority) first,” he said.
For those looking for alternative vaccines, the Sinopharm vaccine has a reported higher efficacy rate compared to the Sinovac vaccine - 79 per cent compared to 51 per cent - and reportedly milder side effects.
Related Stories
Gleneagles Hospital Hong Kong Launches TeleCare SmartHub with SmarTone
IHH Healthcare Singapore and AIA Singapore Partner to Advance Value-based Care
IHH Singapore Advances the Conversation on Healthspan and Longevity
The IHH Sky Race Reaches New Heights at Merdeka 118
Fortis Memorial Research Institute Champions ECMO Excellence at ECMOASIA 2026
On 24-25 July 2026, Fortis Memorial Research Institute (FMRI), Gurugram hosted ECMOASIA 2026, a landmark conference that brought together leading national and international experts to advance awareness, education and clinical excellence in Extracorporeal Membrane Oxygenation (ECMO) care across the Asia-Pacific region.
Pantai Hospital Kuala Lumpur Brings Preventive Care to the Workplace
On 12 August, Pantai Hospital Kuala Lumpur (PHKL) partnered with Unitrade Industries Berhad and AIA Malaysia to deliver an On-Site Influenza Vaccination and Health Screening Programme at Unitrade's premises, bringing accessible preventive care directly to the workplace.
